---
title: Retrospective clinical study on cryopreservation-free integrated autologous
  hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma
date: '2024-07-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38964924/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12iSD5QubOnfg0fkR8dCcveVdPAdI9QKdI-uy_x1YlQTYHygaQ&fc=20221007230549&ff=20240705180243&v=2.18.0.post9+e462414
source: (Hematopoietic Cell Transplantation) AND (Cryopreserved-Grafts)
description: 'Objective: To explore the efficacy and safety of cryopreservation-free
  integrated autologous hematopoietic stem cell transplantation (HSCT) model for patients
  with multiple myeloma. Methods: A total of 96 patients with newly diagnosed multiple
  myeloma (NDMM) between July 31, 2020, and December 31, 2022, were retrospectively
  analyzed, of which 41 patients in the observation group received integrated non-cryopreserved
  transplantation mode. After hematopoietic stem cells were mobilized ...'
disable_comments: true
---
Objective: To explore the efficacy and safety of cryopreservation-free integrated autologous hematopoietic stem cell transplantation (HSCT) model for patients with multiple myeloma. Methods: A total of 96 patients with newly diagnosed multiple myeloma (NDMM) between July 31, 2020, and December 31, 2022, were retrospectively analyzed, of which 41 patients in the observation group received integrated non-cryopreserved transplantation mode. After hematopoietic stem cells were mobilized ...